Back to Search
ALLISON HUTSON, D.O.
D.O.
Internal Medicine Physician
NPI: 1659546778IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
15190(NH)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2008
Research & Publications (20)
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
PMID 19135712·Gynecol Oncol·2009
3-trial
Superimposed gastric aspiration increases the severity of inflammation and permeability injury in a rat model of lung contusion.
PMID 19515386·J Surg Res·2009
7-preclinical
Survival after second-line intraperitoneal therapy for the treatment of epithelial ovarian cancer: the Gynecologic Oncology Group experience.
PMID 19395997·Int J Gynecol Cancer·2009
8-other
The application of genetic markers for EBLV surveillance in European bat species.
PMID 18634497·Dev Biol (Basel)·2008
7-preclinical
Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus.
PMID 18599458·Proc Natl Acad Sci U S A·2008
8-other
Novel nanoparticles for the delivery of recombinant hepatitis B vaccine.
PMID 18640075·Nanomedicine·2008
7-preclinical
A discrete-continuous mixture quantile function estimator with a practical application to phase II cancer clinical trials.
PMID 18038447·Stat Med·2008
8-other
Increased human buccal cell autofluorescence is a candidate biomarker of tobacco smoking.
PMID 18199730·Cancer Epidemiol Biomarkers Prev·2008
8-other
Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
PMID 18483329·Cancer Epidemiol Biomarkers Prev·2008
8-other
Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.
PMID 17481705·Gynecol Oncol·2007
3-trial
Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia.
PMID 17507636·Cancer Epidemiol Biomarkers Prev·2007
8-other
Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates.
PMID 17515875·Pediatr Res·2007
8-other
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
PMID 17987036·Br J Cancer·2007
7-preclinical
Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies.
PMID 17328758·FEMS Immunol Med Microbiol·2007
8-other
A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.
PMID 17317832·Clin Cancer Res·2007
3-trial
Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.
PMID 17962085·Nanomedicine·2007
7-preclinical
Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice.
PMID 17114280·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype.
PMID 17054072·J Infect Dis·2006
8-other
Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein.
PMID 17177807·Plant Biotechnol J·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 MEDICAL CENTER DR, DHMC DEPARTMENT OF MEDICINE
LEBANON, NH 03756 - Phone
- (603) 650-7684
Quick Facts
- NPI
- 1659546778
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile